Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
ENTITY
SMARTSCORE: 3.4/5
3SBio Inc (1530 HK)
Watchlist
Contact IR
98
Analysis
Health Care
•
China
3SBio, Inc. is a biotechnology company located in China. The Company focuses on mammalian cell-based biopharmaceuticals in the biotechnology industry. 3SBio also develops, manufactures and markets biopharmaceutical products globally.
more
Watchlist
Contact IR
Filings
Presentations
Events
Earnings/Op Data
New
Refresh
Exchange Announcement •
25 Mar 2025 11:56
Final Dividend For The Year Ended 31 December 2024
Attachment
Exchange Announcement •
25 Mar 2025 11:55
Annual Results Announcement For The Year Ended 31 December 2024
Attachment
Exchange Announcement •
07 Mar 2025 08:52
Notice Of Board Meeting
Attachment
Exchange Announcement •
13 Jan 2025 09:17
Voluntary Announcement Cooperation Between 3sbio Inc. And Duality Biologics In Respect Of Her2 Adc Drug
Attachment
Exchange Announcement •
18 Dec 2024 10:39
(1) Cancellation Of Treasury Shares; And (2) Change Of Address Of Principal Place Of Business In Hong Kong
Attachment
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.51.2
x